This inventor holds 1 USPTO granted patent. Top assignee: Duke University. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Jacquelyn Lykken: Innovator in Immunotherapy
Introduction
Jacquelyn Lykken is a prominent inventor based in Durham, NC (US). She has made significant contributions to the field of immunotherapy, particularly in the development of antibodies that target specific regulatory bio cells. Her work is crucial in advancing treatment options for individuals with various health conditions.
Latest Patents
Jacquelyn Lykken holds a patent for "Antibodies and methods for depleting regulatory bio cells and use in combination with immune checkpoint inhibitors." This patent outlines methods involving combination therapy that includes administering an antibody that preferentially depletes human B10 cells alongside an immune checkpoint inhibitor. The antibodies developed for these methods are also detailed in her patent.
Career Highlights
Lykken is affiliated with Duke University, where she conducts her research and develops her innovative therapies. Her work has garnered attention for its potential to improve patient outcomes in immunotherapy.
Collaborations
Jacquelyn has collaborated with notable colleagues, including Thomas F. Tedder and Yasuhiro Fujisawa. These partnerships have enhanced her research and contributed to the advancement of her patented methods.
Conclusion
Jacquelyn Lykken is a trailblazer in the field of immunotherapy, with her innovative patent paving the way for new treatment strategies. Her contributions to science and medicine are invaluable and continue to inspire future research.